ANQLAR
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Oct 2025)
What this means for you
This application is over — abandoned 07 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90555318
- Mark type
- Stylized text
- Filed
- 02 Mar 2021
- Published for opposition
- 02 Nov 2021
- Abandoned
- 07 Oct 2025
- Attorney of record
- G Kenneth Smith
Goods and services
- Class 005 — Pharmaceuticals: Amphiphilic carbohydrate formulation for use in the prevention or treatment of a viral infection
Owner
- Virpax Pharmaceuticals Inc., Berwyn, PA, US
- Virpax Pharmaceuticals Inc., Berwyn, PA, US
Prosecution history
- 07 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 28 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jun 2024 — SOU EXTENSION 5 GRANTED
- 28 Jun 2024 — SOU EXTENSION 5 FILED
- 28 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 23 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Feb 2024 — SOU EXTENSION 4 GRANTED
- 28 Dec 2023 — SOU EXTENSION 4 FILED
- 30 Jan 2024 — NOTICE OF REVIVAL - E-MAILED
- 30 Jan 2024 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 30 Jan 2024 — PETITION TO REVIVE-GRANTED
- 30 Jan 2024 — TEAS PETITION TO REVIVE RECEIVED
- 29 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED